KLOR-CON M20 Drug Patent Profile
✉ Email this page to a colleague
When do Klor-con M20 patents expire, and when can generic versions of Klor-con M20 launch?
Klor-con M20 is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in KLOR-CON M20 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klor-con M20
A generic version of KLOR-CON M20 was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KLOR-CON M20?
- What are the global sales for KLOR-CON M20?
- What is Average Wholesale Price for KLOR-CON M20?
Summary for KLOR-CON M20
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 314 |
Patent Applications: | 2,326 |
Drug Sales Revenues: | Drug sales revenues for KLOR-CON M20 |
DailyMed Link: | KLOR-CON M20 at DailyMed |
Pharmacology for KLOR-CON M20
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
US Patents and Regulatory Information for KLOR-CON M20
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upsher Smith Labs | KLOR-CON M20 | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 074726-001 | Nov 20, 1998 | AB1 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |